We found CA could enhance anti-inflammatory cytokine IL-10 level to inhibit inflammatory response, which indicates that CA treatment not only inhibits inflammatory response but also enhances anti-inflammatory capacity in DSS-induced colitis mice. The gene discussed is IL10; the disease is colitis.